Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 10;16(6):e62116.
doi: 10.7759/cureus.62116. eCollection 2024 Jun.

Follicle-Stimulating Hormone Receptor (FSHR) Ser680Asn Genotype Does Not Affect the Follicular Fluid Hormonal Profile in Stimulated Cycles Using Different Gonadotropin Preparations for Ovulation Induction: A Pilot Study

Myrto-Sotiria Papamentzelopoulou  1 , Despoina Mavrogianni  1 , Emmanouela Liokari  2 , Sofoklis Stavros  3 , Anastasios Potiris  3 , Dimitris Doumplis  2   4 , Dimitrios Loutradis  4
Affiliations

Follicle-Stimulating Hormone Receptor (FSHR) Ser680Asn Genotype Does Not Affect the Follicular Fluid Hormonal Profile in Stimulated Cycles Using Different Gonadotropin Preparations for Ovulation Induction: A Pilot Study

Myrto-Sotiria Papamentzelopoulou et al. Cureus. .

Abstract

Background: The existing literature lacks consensus on the effectiveness of utilizing polymorphisms to enhance outcomes in in vitro fertilization (IVF), particularly regarding ovulation induction protocols, oocyte and embryo quality, and pregnancy rates. Therefore, the present pilot study aims to assess whether the composition of different gonadotropin preparations affects the ovarian stimulation protocol concerning follicle-stimulating hormone receptor (FSHR) Ser680Asn genotypes (Ser/Ser, Ser/Asn, and Asn/Asn), in terms of ovulation induction parameters, including oocyte maturation rate, embryo quality, and pregnancy rate.

Methodology: A total of 94 IVF patients underwent treatment using a GnRH antagonist protocol with four distinct gonadotropin preparations: HMG, HMG/hCG, rFSH, and rFSH/hCG. Follicular fluid (FF) samples were pooled for each patient for analysis.

Results: No statistical differences in the FF hormonal profile (progesterone, testosterone, androstenedione, estradiol, FSH, hCG) among the FSHR genotypes were reported either separately for each protocol or in combination for the four different preparations of gonadotropins. The maturation rate of MII oocytes and embryo quality did not differ among women carrying either Ser/Ser, Ser/Asn, or Asn/Asn genotype (p-value=0.475, and p-value=1.000, respectively). Moreover, no statistically significant correlation was revealed among Ser/Ser, Ser/Asn, and Asn/Asn carriers and pregnancy rate (p = 0.588).

Conclusions: FF hormonal analysis of women undergoing IVF using different ovulation induction protocols and carrying either Ser/Ser, Ser/Asn, or Asn/Asn genotype revealed no significant correlations, in terms of maturation rate of MII oocytes, embryo quality, and pregnancy rate, indicating that the FSHR Ser680Asn genotype does not constitute a biomarker for a positive pregnancy outcome. Therefore, the existence of a different mechanism for the expression of FSHR Ser680Asn genotypes in the FF hormonal profile related to stimulated cycles is implied.

Keywords: embryo quality; follicular fluid; fshr ser680asn genotype; hormonal profile; maturation rate; ovulation induction; pregnancy rate.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

See all similar articles

References

    1. Pharmacogenetics in ovarian stimulation--current concepts. Loutradis D, Vlismas A, Drakakis P, Antsaklis A. Ann N Y Acad Sci. 2008;1127:10–19. - PubMed
    1. Evaluating influence of the genotypes in the follicle-stimulating hormone receptor (FSHR) Ser680Asn (rs6166) polymorphism on poor and hyper-responders to ovarian stimulation: a meta-analysis. Pabalan N, Trevisan CM, Peluso C, Jarjanazi H, Christofolini DM, Barbosa CP, Bianco B. J Ovarian Res. 2014;7:285. - PMC - PubMed
    1. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Altmäe S, Hovatta O, Stavreus-Evers A, Salumets A. Hum Reprod Update. 2011;17:813–828. - PubMed
    1. The effect of the allelics of Ser680Asn polymorphisms of follicle-stimulating hormone receptor gene in IVF/ICSI cycles: a systematic review and meta-analysis. Prodromidou A, Dimitroulia E, Mavrogianni D, Kathopoulis N, Pappa KI, Loutradis D. Reprod Sci. 2023;30:428–441. - PubMed
    1. Genetic complexity of FSH receptor function. Gromoll J, Simoni M. Trends Endocrinol Metab. 2005;16:368–373. - PubMed

LinkOut - more resources